Protective Behaviors and Secondary Harms Resulting From Nonpharmaceutical Interventions During the COVID-19 Epidemic in South Africa: Multisite, Prospective Longitudinal Study
Guy Harling(Apple (Israel)), Kobus Herbst(South African Medical Research Council)
Cited by 30
Related Papers
The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2017|108
HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave
|eLife|2021|49
HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: cross-sectional survey
|BMJ Open|2019|45
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)
|Clinical Infectious Diseases|2021|43
Are out‐of‐school adolescents at higher risk of adverse health outcomes? Evidence from 9 diverse settings in sub‐Saharan Africa
|Tropical Medicine & International Health|2019|26